Original Research
Published on 06 Dec 2024
Real-world efficacy and safety of combined first-line treatment with PARP inhibitors and novel hormonal therapy in mCRPC patients with HRR gene mutations
in Cancer Genetics and Oncogenomics
- 1,166 views
Original Research
Published on 06 Dec 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 05 Dec 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 05 Dec 2024
in Cancer Genetics and Oncogenomics
Correction
Published on 04 Dec 2024
in Cancer Genetics and Oncogenomics
Review
Published on 29 Nov 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 29 Nov 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 27 Nov 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 22 Nov 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 22 Nov 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 14 Nov 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 23 Oct 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 22 Oct 2024
in Cancer Genetics and Oncogenomics
Editorial
Published on 18 Oct 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 09 Oct 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 08 Oct 2024
in Cancer Genetics and Oncogenomics
Original Research
Published on 03 Oct 2024
in Cancer Genetics and Oncogenomics